Takeda collaborate with Novadiscovery on in silico clinical simulation to support health technology assessment. Regulatory agencies are increasingly advocating for the expanded use of in silico technology to improve clinical trial efficiency and increase the probability of regulatory success. By incorporating disease modelling and trial simulation in virtual populations in its pipeline development programs, Takeda aims at providing faster access to innovations for patients.
